Remarks on the universal lifelong coccidioidomycosis prophylaxis in lung transplant recipients

被引：3
|
作者：
Al-Obaidi, Mohanad M. [1 ]
Nematollahi, Saman [1 ]
Nix, David E. [1 ,2 ]
Zangeneh, Tirdad T. [1 ]
机构：
[1] Univ Arizona, Dept Med, Div Infect Dis, Tucson, AZ USA
[2] Univ Arizona, Pharm Practice & Sci, Tucson, AZ USA
来源：
CLINICAL INFECTIOUS DISEASES | 2022年 / 74卷 / 10期
关键词：
D O I：
10.1093/cid/ciab878
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1885 / 1886
页数：2
相关论文
共 50 条
  • [41] Impact of Extended CMV Prophylaxis on CMV Infection in Lung Transplant Recipients
    Dorey-Steins, Z.
    Varghese, P.
    Patel, M.
    Marron, R.
    Myers, C. N.
    Mills, N.
    Chowdhury, J. M.
    Priest, S.
    Zhao, H.
    Brown, J. C.
    Mulhall, P.
    Galli, J.
    Shenoy, K. V.
    Cordova, F. C.
    Criner, G. J.
    Mamary, A. J.
    Sehgal, S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [42] CMV Viremia after Discontinuation of Valganciclovir Prophylaxis in Lung Transplant Recipients
    Gift, T.
    Palafox, J.
    Jones, K.
    Imburgia, T.
    Astor, T.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S485 - S485
  • [43] A Comparison of Aspergillus Prophylaxis with Voriconazole versus Isavuconazole in Lung Transplant Recipients
    Nanayakkara, D. D.
    Blodget, E.
    Ganesh, S.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S118 - S119
  • [44] Vancomycin prophylaxis for Clostridium difficile infection among lung transplant recipients
    Bajrovic, Valida
    Budev, Marie
    McCurry, Kenneth R.
    Brizendine, Kyle D.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (08): : 874 - 876
  • [45] Antifungal Prophylaxis in Lung Transplant Recipients: A Network Meta-Analysis
    Herrera, S.
    Foroutan, F.
    Husain, S.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S314 - S315
  • [46] Fungal Colonization and Infection in Lung Transplant Recipients Receiving Posaconazole Prophylaxis
    Cowan, B. E.
    Singer, J. P.
    Shah, R. J.
    Leard, L. E.
    Kukreja, J.
    Chin-Hong, P. V.
    Watkins, K.
    Boettger, R.
    Golden, J. A.
    Hays, S. R.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S308 - S308
  • [47] Cytomegalovirus prophylaxis with IV ganciclovir in lung transplant recipients: The long and the short of it!
    Orens, JB
    [J]. CHEST, 1999, 116 (05) : 1152 - 1153
  • [48] Management and prophylaxis of bacterial and mycobacterial infections among lung transplant recipients
    Okamoto, Koh
    Santos, Carlos A. Q.
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
  • [49] Antifungal Prophylaxis with Voriconazole or Itraconazole in Lung Transplant Recipients: Hepatotoxicity and Effectiveness
    Cadena, J.
    Levine, D. J.
    Angel, L. F.
    Maxwell, P. R.
    Brady, R.
    Sanchez, J. F.
    Michalek, J. E.
    Levine, S. M.
    Restrepo, M. I.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (09) : 2085 - 2091
  • [50] Therapeutic Drug Monitoring in Lung Transplant Recipients Receiving Itraconazole Prophylaxis
    Chong, P.
    Hathcock, M.
    Kremers, W.
    Kennedy, C.
    Razonable, R.
    [J]. TRANSPLANTATION, 2014, 98 : 806 - 806
12345